🇺🇸 FDA
Patent

US 8946291

Compositions and methods for treating pigmentary conditions and melanoma

granted A61KA61K38/1709A61P

Quick answer

US patent 8946291 (Compositions and methods for treating pigmentary conditions and melanoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/1709, A61P, A61P17/00, A61P35/00